A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with ...

A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with ...

With cutting-edge cancer therapies expanding, the debate is shifting from possibility to practicality—who gets treated, when ...

Nation emerges as global hub for bone marrow transplants and cutting-edge cell therapy Also In This Package Patient cells ...

To see your kids hurt and down and you can’t help them…” said mom Denisha DeLee, her voice trailing off. Most pressing is ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY ® ...

Study in adults and children with aplastic anemia identifies parallel evolutionary pathways used by hematopoietic stem cells ...

Aplastic anemia is a rare, life-threatening blood disorder where patients are unable to make enough blood cells due to the ...

Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, after Norgine's ...

Australia TGA approves Specialised Therapeutics’ Niktimvo for the treatment of chronic graft-versus-host disease: Singapore Tuesday, May 5, 2026, 12:00 Hrs [IST] Independent bio ...